MR编号 | SE/H/0541/001 |
---|
药品名称 | Rhesonativ |
---|
活性成分 | - Human anti-D immunoglobulin 625.0 IU/ml
|
---|
剂型 | Solution for injection |
---|
上市许可持有人 | Octapharma AB
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- Portugal (PT)
Rhesonativ - Norway (NO)
- Poland (PL)
Rhesonativ - Latvia (LV)
Rhesonativ 625 SV/ml šķīdums injekcijām - Lithuania (LT)
Rhesonativ 625 TV/ml injekcinis tirpalas - Estonia (EE)
RHESONATIV - Hungary (HU)
Rhesonativ 625 NE/ml oldatos injekció - Cyprus (CY)
25M0179 - Czechia (CZ)
12350/06 - Romania (RO)
Rhesonativ 625 UI/ml solutie injectabila - Slovakia (SK)
Rhesonativ - Slovenia (SI)
- Austria (AT)
Rhesonativ 625 I.E./ml Injektionslösung - France (FR)
- Italy (IT)
- Bulgaria (BG)
- Malta (MT)
|
---|
许可日期 | 2006/03/06 |
---|
最近更新日期 | 2024/11/01 |
---|
药物ATC编码 | - J06BB01 anti-D (rh) immunoglobulin
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier [Article 8.3(i)]
- TypeLevel4:Biological: Blood Product
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|